Literature DB >> 9230001

Emergency department use of aspirin in patients with possible acute myocardial infarction.

B B Saketkhou1, F J Conte, M Noris, P Tilkemeier, G Miller, D E Forman, L Cannistra, J Leavitt, S C Sharma, C Garber, A F Parisi.   

Abstract

BACKGROUND: Efforts have been made to improve the suboptimal use of aspirin after hospitalization.
OBJECTIVE: To assess the frequency and timing of aspirin administration in emergency department patients with possible myocardial infarction.
DESIGN: Retrospective record review.
SETTING: Emergency departments of four hospitals affiliated with the same university. PATIENTS: All patients who were admitted to the four hospitals in 1994 for evaluation and treatment of suspected acute myocardial infarction. MEASUREMENTS: The frequency and timing of aspirin administration and the definitive diagnosis established before discharge from the hospital.
RESULTS: Aspirin was not given to 253 of 463 emergency department patients (55%) who had a definitive diagnosis of acute myocardial infarction. Seventy-eight percent of patients who did receive aspirin received it more than 30 minutes after arrival in the emergency department.
CONCLUSION: Aspirin therapy is underutilized as the first intervention in patients who are admitted with suspected myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9230001     DOI: 10.7326/0003-4819-127-2-199707150-00005

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  2 in total

1.  Emergency department crowding and risk of preventable medical errors.

Authors:  Stephen K Epstein; David S Huckins; Shan W Liu; Daniel J Pallin; Ashley F Sullivan; Robert I Lipton; Carlos A Camargo
Journal:  Intern Emerg Med       Date:  2011-10-19       Impact factor: 3.397

2.  Quality of care for acute myocardial infarction in 58 U.S. emergency departments.

Authors:  Chu-Lin Tsai; David J Magid; Ashley F Sullivan; James A Gordon; Rainu Kaushal; P Michael Ho; Pamela N Peterson; David Blumenthal; Carlos A Camargo
Journal:  Acad Emerg Med       Date:  2010-09       Impact factor: 3.451

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.